European Archives - Page 742 of 1587 - European Medical Journal

EASL 2024 Interview: Sven Francque

During my studies, I was most fascinated by the mechanisms behind diseases. That was what always triggered my interest, as well as trying…

EULAR 2024 Interview: Jette Primdahl

I started my career as a nurse, working for many years in cardiology, a speciality that I really liked. After further education, and…

Spotlight: June 2024

Discover June’s top pharma news in our monthly round-up. From the latest market predictions to new vaccine development initiatives, there’s plenty to discover.

GLP-1 treatments may lower cancer risk in type 2 diabetes patients

A new study finds that patients with type 2 diabetes taking GLP-1 treatments have a reduced chance of developing obesity-related cancers.

EULAR Breaking News: Interferon Signature in Paediatric Sjögren’s Diagnosis

Researchers presented novel findings on the potential utility of the blood interferon signature in diagnosing and stratifying paediatric Sjögren’s disease.

Gestational Carriers Face Higher Health Risks: ESHRE 2024

Research presented at ESHRE 2024 reveals higher risks of severe maternal morbidity and adverse pregnancy outcomes for gestational carriers compared to natural and IVF conceptions.

Air Pollution Linked to Decreased IVF Success: ESHRE 2024

Pioneering research presented at the ESHRE 40th Annual Meeting suggests that exposure to fine particulate matter before the retrieval of oocytes during IVF can impact the odds of achieving a life birth.

Importance of Circulating Tumour Cells in Multiple Myeloma Risk Stratification

A study has highlighted the clinical significance of circulating tumour cells in the blood of multiple myeloma patients, proposing a new cutoff that could enhance treatment outcomes.

Second-hand Smoke Increases Rheumatoid Arthritis Risk

A new study showed a significant association between secondhand smoke exposure and the risk of developing rheumatoid arthritis

New Program Eases Distress and Fatigue in Blood Cancer Patients

A new program has shown promising results in reducing distress and fatigue among blood cancer patients who have undergone haematopoietic stem cell transplants.